Position in PFE
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,997,652
-$448,172 QoQ
Shares Held
82,959
-4.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#964
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Whitener Capital Management, Inc. holds $31,660,073 across 7 Drug Manufacturers - General names. PFE ranks #6 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,935 | $10,552,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,121 | $6,633,950 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,420 | $5,836,470 | |
| 4 | LLY |
ELI LILLY & Co
|
2,960 | $3,550,313 | |
| 5 | AMGN |
Amgen Inc
|
5,665 | $2,051,409 | |
| 6 | PFE |
Pfizer Inc
This page
|
82,959 | $1,997,652 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,214 | $1,037,756 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,997,652 | 82,959 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,445,824 | 87,102 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,087,865 | 83,850 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,016,079 | 79,124 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,820,157 | 75,089 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,840,013 | 72,613 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,984,178 | 74,790 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,523,546 | 52,645 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $906,412 | 32,395 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $990,675 | 35,700 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $993,802 | 34,519 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,598,097 | 48,179 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,788,553 | 48,761 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,030,901 | 49,777 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,615,033 | 51,035 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $2,236,354 | 51,105 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $2,637,491 | 50,305 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,703,170 | 52,215 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,029,855 | 51,310 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,706,378 | 39,674 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,943,902 | 49,640 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,710,164 | 47,203 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,460,399 | 39,674 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,380,285 | 37,610 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $905,136 | 27,680 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $898,577 | 27,530 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||